Two-pronged Cell Therapy: Engineering NK cells to target CD22 and redirect bystander T cells to CD19 for the adoptive imrnunotherapy of B-cell malignancies

被引：0
|
作者：
Szoor, Arpad
Velasquez, Mireya Paulina
Bonifant, Challice Lee
Vaidya, Abishek
Brunetti, Lorenzo
Gundry, Michael
Parihar, Robin
Goodell, Margaret
Gottschalk, Stephen
机构：
来源：
JOURNAL OF IMMUNOLOGY | 2017年 / 198卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
198.6
引用
收藏
页数：4
相关论文
共 50 条
  • [41] CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations
    Jin, Aiyun
    Feng, Jingjing
    Wei, Guoqing
    Wu, Wenjun
    Yang, Luxin
    Xu, Huijun
    Zhang, Yanlei
    Cui, Jiazhen
    Chang, Alex Hongsheng
    Hu, Yongxian
    Huang, He
    BONE MARROW TRANSPLANTATION, 2020, 55 (04) : 717 - 721
  • [42] CD22 Gating for Flow Cytometric Analysis in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia after CD19 CAR-T Therapy
    Yu, Xinjian
    Li, Pan
    Feng, Heyuan
    Kang, Jian
    Zheng, Xichang
    Zhang, Yunmei
    Yang, Wenhong
    Wu, Tong
    Liu, Shuangyou
    BLOOD, 2020, 136
  • [43] A novel loop-structure-based bispecific CAR that targets CD19 and CD22 with enhanced therapeutic efficacy against B-cell malignancies
    Zhao, Lijun
    Li, Shuhong
    Wei, Xiaoyi
    Qi, Xuexiu
    Guo, Qiaoru
    Shi, Licai
    Zhang, Ji-Shuai
    Li, Jun
    Liu, Ze-Lin
    Guo, Zhi
    Zhang, Hongyu
    Feng, Jia
    Shi, Yuanyuan
    Zhang, Suping
    Cao, Yu J.
    PROTEIN & CELL, 2024,
  • [44] Rapid identification of early infections in febrile patients after CD19 target CAR-T cell therapy for B-cell malignancies
    Pu, Lian-Fang
    Zheng, Hui-Min
    Feng, Xiang-Jiang
    Charwudzi, Alice
    Liang, Xue
    Hu, Lin-Hui
    Ding, Yang-Yang
    Liu, Ze-Lin
    Liao, Ya
    Xiong, Shu-Dao
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [45] Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies
    Singh, Harjeet
    Srour, Samer A.
    Milton, Denai R.
    McCarty, Jessica
    Dai, Cuiping
    Gaballa, Mahmoud R.
    Ammari, Mariam
    Olivares, Simon
    Huls, Helen
    De Groot, Eleanor
    Marin, David
    Petropoulos, Demetrios
    Olson, Amanda L.
    Anderlini, Paolo
    Im, Jin S.
    Khouri, Issa
    Hosing, Chitra M.
    Rezvani, Katayoun
    Champlin, Richard E.
    Shpall, Elizabeth J.
    Cooper, Laurence J. N.
    Kebriaei, Partow
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [46] Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients
    Qu, Changju
    Zou, Rui
    Wang, Peng
    Zhu, Qian
    Kang, Liqing
    Ping, Nana
    Xia, Fan
    Liu, Hailing
    Kong, Danqing
    Yu, Lei
    Wu, Depei
    Jin, Zhengming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies
    Garcia-Prieto, Carlos A.
    Villanueva, Lorea
    Bueno-Costa, Alberto
    Davalos, Veronica
    Azucena Gonzalez-Navarro, Europa
    Juan, Manel
    Urbano-Ispizua, Alvaro
    Delgado, Julio
    Ortiz-Maldonado, Valentin
    Del Bufalo, Francesca
    Locatelli, Franco
    Quintarelli, Concetta
    Sinibaldi, Matilde
    Soler, Marta
    Castro de Moura, Manuel
    Ferrer, Gerardo
    Urdinguio, Rocio G.
    Fernandez, Agustin F.
    Fraga, Mario F.
    Bar, Diana
    Meir, Amilia
    Itzhaki, Orit
    Besser, Michal J.
    Avigdor, Abraham
    Jacoby, Elad
    Esteller, Manel
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (03): : 436 - 445
  • [48] A single nucleotide polymorphism in CD19 defines a novel target for immunotherapiy of B cell malignancies with CD4+ cytotoxic T cells
    Spaapen, Robbert M.
    Lokhorst, Henk M.
    van den Oudenalder, Kelly
    Otterud, Brith
    Dolstra, Harry
    Leppert, Mark
    Minnema, Monique C.
    Bloem, Andries C.
    Mutis, Tuna
    BLOOD, 2007, 110 (11) : 533A - 533A
  • [49] CAR-T Cells Targeting BAFF-Receptor for B-Cell Malignancies: A Potential Alternative to CD19
    Qin, Hong
    Dong, Zhenyuan
    Wen, Fen
    Cheng, Wesley
    Sun, Han
    Wei, Guowei
    Smith, Diane Lynne
    Neelapu, Sattva S.
    Wang, Xiuli
    Forman, Stephen J.
    Kwak, Larry W.
    BLOOD, 2017, 130
  • [50] Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies
    Hay, Kevin A.
    Turtle, Cameron J.
    DRUGS, 2017, 77 (03) : 237 - 245
12345